RxDoctor Payments Data

Juliana Lima

Family · Avon, CTNPI 1346721768

Payments from drug & device makers

$1,520in general payments, 2019–2025

Across 87 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Biohaven Pharmaceuticals, Inc.$172
  • Amgen$93
  • Biohaven Pharmaceutical Holding Company Ltd.$64
  • Lilly USA, LLC$60
  • Teva Pharmaceuticals USA, Inc.$28
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$1,520100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,520 in reported general payments places this provider in the 75th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut

Medicare billing

Part B allowed, 2024
$6,087
Medicare patients
60
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate40$328
Levocetirizine Dihydrochloride37$223

Paid to pharmacies, not to this prescriber.

Other family in Avon

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →